BridgeMD
Compares treatment options for Colorectal Cancer
Official title Robotic Versus Laparoscopy NOSE for Stage I-III Left-sided Colon Cancer
ClinicalTrials.gov ID: NCT05970133
What this study is testing
- What it's testing
- In this project, the investigator aims to provide the level 1 evidence for the comparison of robotic versus laparoscopic NOSE for the surgery of stage I-III colorectal cancer. the investigator hypothesize that, with the increased maneuverability of the current robotic system, robotic surgery will be a good option for patients with stage I-III colorectal cancer requiring a NOSE procedure.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Primary colon cancers located at the left sided colonic anatomic location, including distal transverse colon, colonic splenic flexure, descending...
- TNM Stage I III adenocarcinomas;
- Curative and elective surgery;
- American Society of Anesthesiology (ASA) class I to III patients;
- Age \>18 years.
You likely can't join if
- Cecal, ascending, the proximal and middle transverse colon cancers; and the middle or lower rectal cancers;
- Emergency or palliative surgery;
- Evidence of disseminated disease or adjacent organ invasion;
- Primary tumor mass \>8 cm in diameter;
- Morbidly obese patients, that is, body mass index (BMI) ≥40 kg/m 2 ;
- Previous major surgery of upper abdomen or pelvis
The study team makes the final eligibility decision.
Where it's taking place
- Taipei, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taipei, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.